Cargando…

Murine monoclonal antibodies against RBD of the SARS-CoV-2 spike protein as useful analytical tools for subunit vaccine development and clinical trials

COVID-19 pandemic poses a serious threat to human health; it has completely disrupted global stability, making vaccine development an important goal to achieve. Monoclonal antibodies play an important role in subunit vaccines strategies. In this work, nine murine MAbs against the RBD of the SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanco, Omar R., Dorta, Dayamí, Hernández, Carlos A., Abreu, Daymí, Domínguez, Andy G., Luna, Yaramis, Valdivia, Onel, Pérez-Bernal, Maylín, Tamayo, Celia, Lemos, Gilda, Pasarón, Ivis M., Pérez, Joel J., Benítez, Liudmila, Bequet-Romero, Mónica, Fragas, Anitza, Cabrera, Yeosvany, Pérez, Enrique R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619880/ https://www.ncbi.nlm.nih.gov/pubmed/34843713 http://dx.doi.org/10.1016/j.jim.2021.113195

Ejemplares similares

SARS-CoV-2 spike RBD-specific IgA and IgG antibodies in breast milk after vaccination with the protein subunit vaccine Abdala
por: Pérez-Bernal, Maylin, et al.
Publicado: (2022)

Monoclonal antibody generated against Nile tilapia (Oreochromis niloticus) IgT heavy chain using a peptide-based strategy
por: Velázquez, Janet, et al.
Publicado: (2023)

Evaluation of two rapid immunochromatographic tests for diagnosis of brucellosis infection in cattle
por: Quintero, Anitza Fragas, et al.
Publicado: (2018)

A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies
por: Pi-Estopiñan, Franciscary, et al.
Publicado: (2022)

Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
por: Fan, Chengcheng, et al.
Publicado: (2022)

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
por: Huang, Kuan-Ying A., et al.
Publicado: (2022)

Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
por: Ma, Hang, et al.
Publicado: (2022)

La adicción del presupuesto base cero en la legislación presupuestal federal de México /
por: Pasarón Castán, Sariela
Publicado: (2016)

Combination of Recombinant Proteins S1/N and RBD/N as Potential Vaccine Candidates
por: Mendoza-Ramírez, Noe Juvenal, et al.
Publicado: (2023)

Rabbit Monoclonal Antibody Specifically Recognizing a Linear Epitope in the RBD of SARS-CoV-2 Spike Protein
por: Hong, Junping, et al.
Publicado: (2021)

Unravelling the molecular interactions between the SARS-CoV-2 RBD spike protein and various specific monoclonal antibodies
por: Martí, Didac, et al.
Publicado: (2022)

Propuesta de uso de energía solar como alternativa energética sustentable para casa habitación /
por: Ramírez Pasaron, Khrisel Yazmín
Publicado: (2009)

Immunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3–18 years old: a double-blinded, multicentre, randomised, phase 1/2 clinical trial (ISMAELILLO study)
por: Cinza-Estévez, Zurina, et al.
Publicado: (2023)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity
por: Pérez-Rodríguez, Sonia, et al.
Publicado: (2022)

Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)
por: Hernández-Bernal, Francisco, et al.
Publicado: (2022)

Predictors of RBD progression and conversion to synucleinopathies
por: de Natale, Edoardo Rosario, et al.
Publicado: (2022)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Generalized EEG Slowing Across Phasic REM Sleep, Not Subjective RBD Severity, Predicts Neurodegeneration in Idiopathic RBD
por: Gong, Si-Yi, et al.
Publicado: (2022)

Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
por: Rattanapisit, Kaewta, et al.
Publicado: (2020)

Characterization of the C6D7-RBD Human Monoclonal Antibody Specific to the SARS-CoV-2 S Protein Receptor-Binding Domain
por: Romanenko, Ya. O., et al.
Publicado: (2023)

Activation of p38 Mitogen-Activated Protein Kinase Promotes Epidermal Growth Factor Receptor Internalization
por: Vergarajauregui, Silvia, et al.
Publicado: (2006)

Reduced Intracortical Facilitation to TMS in Both Isolated REM Sleep Behavior Disorder (RBD) and Early Parkinson’s Disease with RBD
por: Lanza, Giuseppe, et al.
Publicado: (2022)

Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells
por: Gerez, Guillaume, et al.
Publicado: (2022)

Effectiveness of a Computer-Based Training Program of Attention and Memory in Patients with Acquired Brain Damage
por: Fernandez, Elizabeth, et al.
Publicado: (2017)

Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug
por: Benítez-Cardoza, Claudia Guadalupe, et al.
Publicado: (2020)

Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies
por: Ding, Chengchao, et al.
Publicado: (2021)

Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape
por: Zhao, Zhennan, et al.
Publicado: (2022)

Contribution of dsRBD2 to PKR Activation
por: Hesler, Stephen, et al.
Publicado: (2021)

Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Development of a scalable single process for producing SARS-CoV-2 RBD monomer and dimer vaccine antigens
por: Boggiano-Ayo, Tammy, et al.
Publicado: (2023)

Recombinant Antigens Based on Non-Glycosylated Regions from RBD SARS-CoV-2 as Potential Vaccine Candidates against COVID-19
por: Núñez-Muñoz, Leandro, et al.
Publicado: (2021)

Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody
por: Meng, Xianmin, et al.
Publicado: (2021)

Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
por: Rattanapisit, Kaewta, et al.
Publicado: (2021)

Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination
por: Chen, Yuxin, et al.
Publicado: (2021)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

Preparation of a Functional Rat LDL Receptor Minigene
por: Wooten, Catherine J., et al.
Publicado: (2019)

Deep learning for numerical applications with SAS
por: Bequet, Henry
Publicado: (2018)

Trois bibliothèques européennes face à Google: à l'origine de la bibliothèque numérique (1990-2010)
por: Béquet, Gaëlle
Publicado: (2015)

Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination
por: Hernández-Luis, Pablo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v35cm0e5c937n7id6jbbr06gni